Hyponatremia is the Primary Electrolyte Disturbance Causing Raised Intracranial Pressure
Hyponatremia (serum sodium <135 mmol/L) is the most common electrolyte disorder that causes raised intracranial pressure in adults, occurring in up to 50% of neurosurgical patients and leading to cerebral edema through osmotically-driven water movement into brain cells 1, 2.
Mechanism and Clinical Significance
Hyponatremia causes cerebral edema and increased intracranial pressure by driving water from the extracellular compartment into brain cells osmotically 2. This is particularly dangerous in neurosurgical patients who may develop severe cerebral edema, mental status changes, seizures, vasospasm, and death 1. The neurologic complications are directly attributable to the increased intracranial pressure from brain swelling 2.
When to Investigate and Treat
Hyponatremia should be investigated and treated when serum sodium falls below 131 mmol/L 1. The evaluation should combine:
- Physical examination findings
- Basic laboratory studies (serum sodium, plasma osmolality, urine sodium, urine osmolality)
- Invasive monitoring when available (central venous pressure)
Notably, obtaining hormone levels such as antidiuretic hormone and natriuretic peptides is not supported by evidence 1.
Treatment Algorithm Based on Symptom Severity
Symptomatic/Acute Hyponatremia
For symptomatic hyponatremia with neurologic manifestations (altered mental status, seizures, signs of increased ICP), use hypertonic saline (3%) as a 100-150 mL intravenous bolus 3. This is the preferred approach for rapid correction in symptomatic patients.
Critical safety limit: Do not correct serum sodium by more than 10 mmol/L per day 1. This prevents osmotic demyelinating syndrome, which can occur with overly rapid correction and cause permanent neurologic damage 2.
Specific Etiologies and Their Management
Cerebral Salt Wasting (CSW):
- Treat with replacement of serum sodium AND intravenous fluids 1
- Do NOT restrict fluids in these patients
Syndrome of Inappropriate Antidiuretic Hormone (SIADH):
- May be treated with urea, diuretics, lithium, demeclocycline, and/or fluid restriction 1
- Fluid restriction of 500 mL/day adjusted according to sodium levels for asymptomatic cases 4
Special Consideration for Subarachnoid Hemorrhage:
- Fludrocortisone may be considered in SAH patients at risk of vasospasm (Class I evidence) 1
- Hydrocortisone may be used to prevent natriuresis in SAH patients 1
- Do NOT treat with fluid restriction in SAH patients at risk of vasospasm 1
Monitoring Requirements
Frequent biochemical monitoring is essential during correction, particularly when using hypertonic saline 3, 4. The speed of correction depends on symptom severity and persistence, requiring serial sodium measurements to avoid overcorrection.
Common Pitfalls to Avoid
Overcorrection: Correcting too rapidly (>10 mmol/L/day) can cause osmotic demyelination syndrome, which may be as catastrophic as the hyponatremia itself 1, 2
Misidentifying the etiology: Distinguishing between CSW and SIADH is critical—CSW requires fluid replacement while SIADH may require fluid restriction 1
Fluid restriction in SAH: This can worsen vasospasm risk and should be avoided 1
Treating asymptomatic mild hyponatremia too aggressively: These patients benefit from adequate solute intake and initial fluid restriction rather than hypertonic saline 4
The evidence strongly supports that hyponatremia is the electrolyte disturbance most directly linked to raised ICP through cerebral edema, and treatment must balance the urgency of symptom relief against the risk of overcorrection complications 1, 2.